Evidence map›Paper›PMID 29968771›Full record

ArticleScientific reports2018

Antibody responses to α-Gal in African children vary with age and site and are associated with malaria protection.

Ruth Aguilar, Itziar Ubillos, Marta Vidal, Núria Balanza, Núria Crespo, Alfons Jiménez, Augusto Nhabomba, Chenjerai Jairoce, David Dosoo, Ben Gyan and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Gut microbiota influencesNew microbes and new infections · 2025
    Article
  6. Is Zebrafish a Good Model for the Alpha-Gal Syndrome?FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  7. Observational
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Compounds targeting GPI biosynthesis orComputational and structural biotechnology journal · 2022
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 3 countries.

Ruth AguilarISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.
Itziar UbillosISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.
Marta VidalISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.
Núria BalanzaISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.
Núria CrespoISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.
Alfons JiménezISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.
Augusto NhabombaCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Chenjerai JairoceCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
David DosooKintampo Health Research Center, Kintampo, Ghana.
Ben GyanKintampo Health Research Center, Kintampo, Ghana.
Aintzane AyestaranISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.
Hèctor SanzISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.
Joseph J CampoISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.
Gloria P Gómez-PérezISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.
Luis IzquierdoISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain. luis.izquierdo@isglobal.org.ORCID 0000-0002-3704-9874
Carlota DobañoISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain. carlota.dobano@isglobal.org.ORCID 0000-0002-6751-4060
Barcelona Institute for Global Health · ESKintampo Health Research Centre · GHManhiça Health Research Centre · MZ

Funding

Understanding RTS,S malaria vaccine-induced protection through integrated analysiR01AI095789 · NIAID · BARCELONA INTERNATIONAL HEALTH RES CTR · PI DOBANO, CARLOTA · 2012 to 2016
$3.2M
NIAID NIH HHS R01 AI095789
6 · The paper itself

Abstract

Naturally-acquired antibody responses to malaria parasites are not only directed to protein antigens but also to carbohydrates on the surface of Plasmodium protozoa. Immunoglobulin M responses to α-galactose (α-Gal) (Galα1-3Galβ1-4GlcNAc-R)-containing glycoconjugates have been associated with protection from P. falciparum infection and, as a result, these molecules are under consideration as vaccine targets; however there are limited field studies in endemic populations. We assessed a wide breadth of isotype and subclass antibody response to α-Gal in children from Mozambique (South East Africa) and Ghana (West Africa) by quantitative suspension array technology. We showed that anti-α-Gal IgM, IgG and IgG

Indexed as

AfricaAge FactorsAntibodiesAntibodies, ProtozoanAntibody FormationAntigens, ProtozoanBlack PeopleChild, PreschoolFemaleGalactoseGhanaHumansImmunoglobulin IsotypesInfantMalariaMalaria, FalciparumAntibodiesAntibodies, ProtozoanAntigens, ProtozoanGalactoseImmunoglobulin IsotypesMalaria Vaccines

Identifiers

PMID29968771
PMCPMC6030195
OpenAlexW2811394164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.